FDA breakthrough device designation strengthens Osteoboost outlook

FDA breakthrough device designation strengthens Osteoboost outlook

https://www.bioworld.com/articles/501468-fda-breakthrough-device-designation-strengthens-osteoboost-outlook?v=preview

Bone Health Technologies Inc. may be on the verge of upstaging a common drug therapy, but don’t tell them to break a leg. The San Francisco-based company’s Osteoboost Vibration Belt received a U.S. FDA breakthrough designation for technology that delivers gentle stimulation to reduce bone loss and prevent osteoporosis with the goal of reducing the number of potentially devastating broken bones in the elderly.